User contributions for Abdurahman Khalil
Jump to navigation
Jump to search
3 April 2014
- 21:2621:26, 3 April 2014 diff hist −7,092 Carvedilol Undo revision 962338 by Abdurahman Khalil (talk)
- 21:2521:25, 3 April 2014 diff hist +7,092 Carvedilol No edit summary
- 19:1119:11, 3 April 2014 diff hist +11,016 Carvedilol No edit summary
- 18:5118:51, 3 April 2014 diff hist +14,122 Carvedilol No edit summary
- 18:4018:40, 3 April 2014 diff hist +12,168 Carvedilol No edit summary
- 14:0414:04, 3 April 2014 diff hist +1,957 Carvedilol No edit summary
- 11:2111:21, 3 April 2014 diff hist +10 Carvedilol No edit summary
- 11:1711:17, 3 April 2014 diff hist +38 Carvedilol Undo revision 962143 by Abdurahman Khalil (talk)
- 11:1711:17, 3 April 2014 diff hist −1,391 Carvedilol No edit summary
- 11:1211:12, 3 April 2014 diff hist +449 Carvedilol No edit summary
- 10:5810:58, 3 April 2014 diff hist +5,525 Cilostazol No edit summary
- 10:5110:51, 3 April 2014 diff hist −31 Cilostazol No edit summary
- 10:4110:41, 3 April 2014 diff hist +780 Cilostazol No edit summary
- 02:4502:45, 3 April 2014 diff hist −7 Cilostazol No edit summary
- 02:0602:06, 3 April 2014 diff hist +36 Cilostazol No edit summary
- 02:0202:02, 3 April 2014 diff hist +143 Cilostazol No edit summary
- 01:1601:16, 3 April 2014 diff hist −3 Cilostazol No edit summary
- 00:4700:47, 3 April 2014 diff hist −75 Cilostazol No edit summary
- 00:4500:45, 3 April 2014 diff hist +90 Cilostazol No edit summary
- 00:3600:36, 3 April 2014 diff hist +29,190 Cilostazol No edit summary
- 00:0200:02, 3 April 2014 diff hist +448 Cilostazol No edit summary
2 April 2014
- 23:4123:41, 2 April 2014 diff hist +32 Cilostazol →Off-Label Use and Dosage (Adult)
- 18:5418:54, 2 April 2014 diff hist −58 Cilostazol →FDA-Labeled Indications and Dosage (Adult)
- 18:4818:48, 2 April 2014 diff hist +709 Cilostazol →Condition 2
- 18:2718:27, 2 April 2014 diff hist −1 Cilostazol →Secondary prevention of stroke and TIA
- 18:1418:14, 2 April 2014 diff hist +775 Cilostazol →Condition 1
- 17:5317:53, 2 April 2014 diff hist −13 Cilostazol →Aspirin
- 17:5217:52, 2 April 2014 diff hist −102 Cilostazol →Chronic Overdose
- 17:4817:48, 2 April 2014 diff hist +67 Cilostazol →Management
- 17:4617:46, 2 April 2014 diff hist +78 Cilostazol →Monitoring
- 17:4417:44, 2 April 2014 diff hist +74 Cilostazol →Labor and Delivery
- 17:3817:38, 2 April 2014 diff hist −3 Cilostazol →Adverse Reactions
- 17:3517:35, 2 April 2014 diff hist +652 Cilostazol →Warnings
- 15:3815:38, 2 April 2014 diff hist +2,597 Cilostazol →Drug Interactions
- 15:2415:24, 2 April 2014 diff hist +1,142 Cilostazol →Drug 1
- 15:0815:08, 2 April 2014 diff hist −761 Cilostazol →Pediatric Indications and Dosage
- 14:5014:50, 2 April 2014 diff hist 0 Cilostazol →Package and Label Display Panel
- 14:4914:49, 2 April 2014 diff hist 0 N File:Cilostazollabel1.png No edit summary current
- 14:4514:45, 2 April 2014 diff hist 0 N File:Cilostazollabel.jpg No edit summary current
- 14:4214:42, 2 April 2014 diff hist +151 Cilostazol →Package and Label Display Panel
- 14:3314:33, 2 April 2014 diff hist 0 N File:Cilostazol100mg.jpg No edit summary current
- 14:3314:33, 2 April 2014 diff hist 0 N File:Cilostazol50mg.jpg No edit summary current
- 14:3114:31, 2 April 2014 diff hist +575 Cilostazol →Drug Images
- 11:2411:24, 2 April 2014 diff hist −1,192 Cilostazol →IV Compatibility
- 11:2211:22, 2 April 2014 diff hist +1,983 Cilostazol →Postmarketing Experience
- 11:1611:16, 2 April 2014 diff hist +1,236 Cilostazol →Clinical Trials Experience
- 11:0411:04, 2 April 2014 diff hist +46 Cilostazol →Central Nervous System
- 11:0211:02, 2 April 2014 diff hist +361 Cilostazol →Gastrointestinal
- 10:5910:59, 2 April 2014 diff hist −1 Cilostazol →Respiratory
- 10:5810:58, 2 April 2014 diff hist +103 Cilostazol →Respiratory
- 10:5510:55, 2 April 2014 diff hist +437 Cilostazol →Cardiovascular
- 10:3410:34, 2 April 2014 diff hist +1 Cilostazol →Contraindications
- 10:1410:14, 2 April 2014 diff hist +106 Cilostazol →Miscellaneous
- 10:1310:13, 2 April 2014 diff hist +12 Cilostazol →Intermittent claudication
- 10:0910:09, 2 April 2014 diff hist +510 Cilostazol →Condition 1
- 09:5609:56, 2 April 2014 diff hist +10 Cilostazol →Brand Names
- 09:5409:54, 2 April 2014 diff hist +1,179 Cilostazol →Pharmacology
- 09:5209:52, 2 April 2014 diff hist +5,659 Cilostazol →Pharmacology
- 09:4109:41, 2 April 2014 diff hist +190 Cilostazol →Gender
- 09:3609:36, 2 April 2014 diff hist −770 Cilostazol detailed information →How Supplied current
- 09:3609:36, 2 April 2014 diff hist +673 Cilostazol →How Supplied
- 09:3509:35, 2 April 2014 diff hist +3,003 Cilostazol →Clinical Studies
- 09:3409:34, 2 April 2014 diff hist +574 Cilostazol →Signs and Symptoms
- 09:3409:34, 2 April 2014 diff hist −72 Cilostazol →Administration and Monitoring
- 09:3209:32, 2 April 2014 diff hist −18 Cilostazol →Administration
- 09:3009:30, 2 April 2014 diff hist +574 Cilostazol detailed information →Signs and Symptoms
- 09:2509:25, 2 April 2014 diff hist +674 Cilostazol detailed information →How Supplied
- 09:1809:18, 2 April 2014 diff hist +3,003 Cilostazol detailed information →Clinical Studies
1 April 2014
- 19:3619:36, 1 April 2014 diff hist +922 Cilostazol →Carcinogenesis, Mutagenesis, Impairment of Fertility
- 19:2619:26, 1 April 2014 diff hist +291 Cilostazol →Renal Impairment
- 19:2519:25, 1 April 2014 diff hist +149 Cilostazol →Hepatic Impairment
- 19:2519:25, 1 April 2014 diff hist +2,167 Cilostazol →Use in Specific Populations
- 18:4918:49, 1 April 2014 diff hist +109 Cilostazol →Contraindications
- 18:3718:37, 1 April 2014 diff hist −78 Cilostazol No edit summary
- 18:3718:37, 1 April 2014 diff hist +20 Cilostazol No edit summary
- 18:2718:27, 1 April 2014 diff hist +61 Cilostazol →Overview
- 18:1818:18, 1 April 2014 diff hist +1 Cilostazol →Patient Information from FDA
- 18:1718:17, 1 April 2014 diff hist +4 Cilostazol →Patient Information from FDA
- 18:1718:17, 1 April 2014 diff hist +19,805 Cilostazol No edit summary
- 18:1418:14, 1 April 2014 diff hist +20 Cilostazol detailed information →Patient Information from FDA
- 18:1318:13, 1 April 2014 diff hist +4,990 Cilostazol detailed information →Patient Information from FDA
- 18:1018:10, 1 April 2014 diff hist +65 Cilostazol detailed information →Patient Information from NLM
- 18:0718:07, 1 April 2014 diff hist +41 Cilostazol detailed information →Overview
- 17:5617:56, 1 April 2014 diff hist +48 Cilostazol detailed information Undo revision 961563 by Abdurahman Khalil (talk)
- 17:5417:54, 1 April 2014 diff hist +292 Cilostazol detailed information →Black Box Warning
- 17:4417:44, 1 April 2014 diff hist +11,138 Cilostazol detailed information No edit summary
- 15:2415:24, 1 April 2014 diff hist +263 Digoxin No edit summary
- 15:0215:02, 1 April 2014 diff hist −2 Digoxin →Patient Information from FDA
- 14:5614:56, 1 April 2014 diff hist −21 Digoxin →FDA-Labeled Indications and Dosage (Pediatric)
- 14:5414:54, 1 April 2014 diff hist −67 Digoxin →FDA-Labeled Indications and Dosage (Adult)
- 14:4714:47, 1 April 2014 diff hist +861 Digoxin →Patient Information
- 14:4414:44, 1 April 2014 diff hist 0 N File:Digoxinsolution.jpg No edit summary current
- 14:4314:43, 1 April 2014 diff hist 0 N File:Digoxinsolution1.png No edit summary current
- 14:4314:43, 1 April 2014 diff hist +222 Digoxin →Images
- 14:3814:38, 1 April 2014 diff hist +14 Digoxin →How Supplied
- 14:2914:29, 1 April 2014 diff hist +28 Digoxin →Drug Images
- 14:2814:28, 1 April 2014 diff hist +18 Digoxin →How Supplied
- 14:2714:27, 1 April 2014 diff hist +877 Digoxin →How Supplied
- 14:1614:16, 1 April 2014 diff hist +8 Digoxin →FDA-Labeled Indications and Dosage (Adult)
- 14:1414:14, 1 April 2014 diff hist +56 Digoxin →FDA-Labeled Indications and Dosage (Pediatric)
- 13:5613:56, 1 April 2014 diff hist +4 Digoxin →FDA-Labeled Indications and Dosage (Adult)
- 13:5413:54, 1 April 2014 diff hist +9 Digoxin →FDA-Labeled Indications and Dosage (Adult)
- 13:4813:48, 1 April 2014 diff hist 0 N File:Lanoxintablet3.png No edit summary current
- 13:4813:48, 1 April 2014 diff hist 0 N File:Digoxininjection1.png No edit summary current
- 13:4713:47, 1 April 2014 diff hist +80 Digoxin →Images
- 13:4213:42, 1 April 2014 diff hist −561 Digoxin →Off-Label Use and Dosage (Adult)
- 13:4013:40, 1 April 2014 diff hist 0 N File:Digoxininjection.jpg No edit summary current
- 13:3913:39, 1 April 2014 diff hist 0 N File:Lanoxintablet2.jpg No edit summary current
- 13:3813:38, 1 April 2014 diff hist +270 Digoxin →Package and Label Display Panel
- 13:2713:27, 1 April 2014 diff hist +1,772 Digoxin →Drug Interactions
- 13:2513:25, 1 April 2014 diff hist −1 Digoxin →Drug Interactions
- 13:2413:24, 1 April 2014 diff hist +843 Digoxin →Drug Interactions
- 13:1513:15, 1 April 2014 diff hist +2,660 Digoxin →Administration
- 13:0313:03, 1 April 2014 diff hist +5 Digoxin →Management
- 13:0113:01, 1 April 2014 diff hist +9 Digoxin →Management
- 12:5612:56, 1 April 2014 diff hist +16 Digoxin →Acute Overdose
- 12:5412:54, 1 April 2014 diff hist +65 Digoxin →Nonclinical Toxicology
- 12:5212:52, 1 April 2014 diff hist −289 Digoxin →Off-Label Use and Dosage (Pediatric)
- 12:5012:50, 1 April 2014 diff hist −1,201 Digoxin →IV Compatibility
- 12:4912:49, 1 April 2014 diff hist +2,825 Digoxin →Clinical Studies
31 March 2014
- 21:1221:12, 31 March 2014 diff hist +6 Digoxin →Drug Images
- 21:1121:11, 31 March 2014 diff hist 0 N File:Lanoxintablet1.jpg No edit summary current
- 21:0621:06, 31 March 2014 diff hist +24 Digoxin →Drug Images
- 20:5020:50, 31 March 2014 diff hist +59 Digoxin →Patient Information from NLM
- 20:3720:37, 31 March 2014 diff hist +1 Digoxin →Structure
- 20:3520:35, 31 March 2014 diff hist −2 Digoxin →How Supplied
- 20:3420:34, 31 March 2014 diff hist +1,262 Digoxin →How Supplied
- 20:2620:26, 31 March 2014 diff hist −71 Digoxin →Pharmacology
- 20:1920:19, 31 March 2014 diff hist −2 Digoxin →Drug Interactions
- 19:5519:55, 31 March 2014 diff hist +1 DIGOXIN injection dosage and administration →Switching from Intravenous Digoxin to Oral Digoxin
- 19:5519:55, 31 March 2014 diff hist +253 Digoxin →Administration and Monitoring
- 19:2419:24, 31 March 2014 diff hist −121 Digoxin →Look-Alike Drug Names
- 19:1619:16, 31 March 2014 diff hist +17 Digoxin →Brand Names
- 19:1219:12, 31 March 2014 diff hist +140 Digoxin →Signs and Symptoms
- 19:1019:10, 31 March 2014 diff hist +852 Digoxin →Management
- 19:0919:09, 31 March 2014 diff hist +1,713 Digoxin →Management
- 19:0819:08, 31 March 2014 diff hist +3,360 Digoxin →Signs and Symptoms
- 19:0519:05, 31 March 2014 diff hist 0 Digoxin →Compatible
- 19:0119:01, 31 March 2014 diff hist −6 Digoxin →Administration
- 19:0019:00, 31 March 2014 diff hist +1,034 Digoxin →Monitoring
- 17:5917:59, 31 March 2014 diff hist −33 Digoxin →Pharmacology
- 17:5817:58, 31 March 2014 diff hist −11 Digoxin →Pharmacology
- 16:4816:48, 31 March 2014 diff hist +216 Digoxin →Contraindications
- 16:3816:38, 31 March 2014 diff hist +1,827 Digoxin →Use in Specific Populations
- 16:1616:16, 31 March 2014 diff hist +216 Digoxin No edit summary
- 16:1416:14, 31 March 2014 diff hist −28 Digoxin →Mechanism of Action
- 16:1316:13, 31 March 2014 diff hist +9,508 Digoxin →Pharmacology
- 15:5315:53, 31 March 2014 diff hist +1,351 Digoxin →Patient Information from FDA
- 15:0515:05, 31 March 2014 diff hist +1,460 Digoxin →Use in Specific Populations
- 15:0215:02, 31 March 2014 diff hist +2,825 Digoxin →Drug Interactions
- 14:5914:59, 31 March 2014 diff hist +1,017 Digoxin →Adverse Reactions
- 14:5614:56, 31 March 2014 diff hist +1,622 Digoxin →Non–Guideline-Supported Use
- 14:5514:55, 31 March 2014 diff hist +377 Digoxin →FDA-Labeled Indications and Dosage (Pediatric)
- 14:4714:47, 31 March 2014 diff hist +779 Digoxin No edit summary
27 March 2014
- 18:5818:58, 27 March 2014 diff hist 0 Digoxin No edit summary
- 18:5718:57, 27 March 2014 diff hist +5,671 Digoxin No edit summary
26 March 2014
- 17:2217:22, 26 March 2014 diff hist 0 Digoxin No edit summary
- 17:2017:20, 26 March 2014 diff hist 0 Digoxin tablet →Postmarketing Experience
- 17:1517:15, 26 March 2014 diff hist 0 Lanoxin tablet No edit summary current
- 17:1317:13, 26 March 2014 diff hist +18,588 N Digoxin tablet Created page with "{{Sandboxrx1}} <div style="width: 80%"> __NOTOC__ {{CMG}} '''''For information about (Generic Name), click here.''''' ==Disclaimer== '''''WikiDoc Drug Pr..."
- 17:1317:13, 26 March 2014 diff hist −3,183 Digoxin No edit summary
- 17:1217:12, 26 March 2014 diff hist −25 Digoxin →Lanoxin (digoxin) tablet
- 17:1017:10, 26 March 2014 diff hist −14 Digoxin No edit summary
25 March 2014
- 19:1519:15, 25 March 2014 diff hist +1,315 Lanoxin tablet →Drug Interactions
- 18:4318:43, 25 March 2014 diff hist −3 Lanoxin tablet →Adverse Reactions
- 16:1216:12, 25 March 2014 diff hist +2 Lanoxin tablet →FDA-Labeled Indications and Dosage (Pediatric)
- 16:1116:11, 25 March 2014 diff hist +33 Lanoxin tablet →FDA-Labeled Indications and Dosage (Adult)
- 16:0916:09, 25 March 2014 diff hist +2 Lanoxin tablet →FDA-Labeled Indications and Dosage (Pediatric)
- 15:2015:20, 25 March 2014 diff hist +6 Lanoxin tablet →FDA-Labeled Indications and Dosage (Pediatric)
- 15:1915:19, 25 March 2014 diff hist +15 Lanoxin tablet →FDA-Labeled Indications and Dosage (Pediatric)
- 15:1815:18, 25 March 2014 diff hist +2 Digoxin No edit summary
- 15:1715:17, 25 March 2014 diff hist −22 Lanoxin tablet →FDA-Labeled Indications and Dosage (Pediatric)
- 15:0015:00, 25 March 2014 diff hist +3 Lanoxin tablet →FDA-Labeled Indications and Dosage (Pediatric)
- 14:5914:59, 25 March 2014 diff hist +2 Lanoxin tablet →FDA-Labeled Indications and Dosage (Pediatric)
- 14:5914:59, 25 March 2014 diff hist +2,178 Lanoxin tablet →Pediatric Indications and Dosage
- 14:4014:40, 25 March 2014 diff hist −1 Lanoxin tablet →Use in Specific Populations
- 14:3914:39, 25 March 2014 diff hist −11 Lanoxin tablet →Contraindications
- 13:3413:34, 25 March 2014 diff hist −179 Lopressor injection →Overview
24 March 2014
- 17:0017:00, 24 March 2014 diff hist +8,924 Lanoxin tablet No edit summary
- 16:5516:55, 24 March 2014 diff hist +4,622 Sandboxak No edit summary current
- 16:1216:12, 24 March 2014 diff hist −11 Lopressor injection →Contraindications
- 15:5515:55, 24 March 2014 diff hist +9,382 N Sandboxak Created page with "{{Lanoxin tablet}} <div style="width: 80%"> __NOTOC__ {{CMG}} '''''For information about (Generic Name), click here.''''' ==Disclaimer== '''''WikiDoc Dru..."
- 03:4703:47, 24 March 2014 diff hist +3,161 WBR1057 No edit summary
- 03:4703:47, 24 March 2014 diff hist +49 N WBR1057 Created page with "{{WBRQuestion |QuestionAuthor=dsc |Approved=No }}"
- 00:1500:15, 24 March 2014 diff hist +2,306 WBR1056 No edit summary
- 00:0100:01, 24 March 2014 diff hist +3,010 N WBR1056 Created page with "{{WBRQuestion |QuestionAuthor={{AK}} |ExamType=USMLE Step 2 CK |MainCategory=Internal medicine, OB/GYN |SubCategory=Genitourinary, Infectious Disease |MainCategory=Internal me..."
23 March 2014
- 23:0923:09, 23 March 2014 diff hist +488 WBR1055 No edit summary
- 23:0923:09, 23 March 2014 diff hist +210 WBR1055 No edit summary
- 23:0823:08, 23 March 2014 diff hist −473 WBR1055 No edit summary
20 March 2014
- 20:3620:36, 20 March 2014 diff hist +22 Lanoxin tablet/pharmacology →Pharmacodynamic and Clinical Effects current
- 20:3120:31, 20 March 2014 diff hist +17 Lanoxin tablet/pharmacology No edit summary
- 20:3120:31, 20 March 2014 diff hist +10,598 N Lanoxin tablet/pharmacology Created page with "__NOTOC__ {{Lanoxin tablet}} {{CMG}}; {{AE}} {{AK}} ===Mechanism of Action=== Digoxin inhibits sodium-potassium ATPase, an enzyme that regulates the quantity of sodium and p..."
- 19:5619:56, 20 March 2014 diff hist +7,461 N Lanoxin tablet/overdosage Created page with "__NOTOC__ {{Lanoxin tablet}} {{CMG}}; {{AE}} {{AK}} ===Signs and Symptoms=== The signs and symptoms of toxicity are generally similar to those described in the ADVERSE REACT..." current
- 19:4219:42, 20 March 2014 diff hist +71 N Lanoxin tablet/IV compatibility Created page with "__NOTOC__ {{Lanoxin tablet}} {{CMG}}; {{AE}} {{AK}} {{DrugReflist}}" current
- 19:3519:35, 20 March 2014 diff hist +70 N Lanoxin tablet/routes and preparations Created page with "__NOTOC__ {{Lanoxin tablet}} {{CMG}}; {{AE}} {{AK}} {{DrugReflist}}" current
- 19:2019:20, 20 March 2014 diff hist −2 Lanoxin tablet/pediatric indications and dosage No edit summary current
- 19:1919:19, 20 March 2014 diff hist −1 Lanoxin tablet/pediatric indications and dosage No edit summary
- 19:1919:19, 20 March 2014 diff hist +10 Lanoxin tablet/pediatric indications and dosage No edit summary
- 17:0617:06, 20 March 2014 diff hist +1,464 Lanoxin tablet/use in specific populations No edit summary current
- 17:0417:04, 20 March 2014 diff hist +16 Lanoxin tablet/adult indications and dosage No edit summary current
- 17:0117:01, 20 March 2014 diff hist +395 N Lanoxin tablet/use in specific populations Created page with "__NOTOC__ {{Lanoxin tablet}} {{CMG}}; {{AE}} {{AK}} ===Teratogenic Effects=== '''Pregnancy Category C'''. Animal reproduction studies have not been conducted with digoxi..."
- 16:5716:57, 20 March 2014 diff hist +2,858 N Lanoxin tablet/drug interactions Created page with "__NOTOC__ {{Lanoxin tablet}} {{CMG}}; {{AE}} {{AK}} Potassium-depleting diuretics are a major contributing factor to digitalis toxicity.Calcium, particularly if administ..." current
- 16:4716:47, 20 March 2014 diff hist +17 Lanoxin tablet/adverse reactions No edit summary current
- 16:4616:46, 20 March 2014 diff hist −14 Lanoxin tablet/adult indications and dosage No edit summary
- 16:4616:46, 20 March 2014 diff hist −14 Lanoxin tablet/contraindications No edit summary current
- 16:4516:45, 20 March 2014 diff hist +30 Lanoxin tablet/contraindications No edit summary
- 16:4016:40, 20 March 2014 diff hist +28 Lanoxin tablet/adult indications and dosage No edit summary
- 16:3316:33, 20 March 2014 diff hist +1,080 Lanoxin tablet/adverse reactions No edit summary
- 16:1916:19, 20 March 2014 diff hist +507 Lanoxin tablet/pediatric indications and dosage No edit summary
- 15:3515:35, 20 March 2014 diff hist +2 Lanoxin tablet/pediatric indications and dosage No edit summary
- 15:3515:35, 20 March 2014 diff hist +20 Lanoxin tablet/pediatric indications and dosage No edit summary
- 15:3315:33, 20 March 2014 diff hist −1 Lanoxin tablet/pediatric indications and dosage No edit summary
- 15:3215:32, 20 March 2014 diff hist +1 Lanoxin tablet/pediatric indications and dosage No edit summary
- 15:3215:32, 20 March 2014 diff hist +1,288 Lanoxin tablet/pediatric indications and dosage No edit summary
- 15:2915:29, 20 March 2014 diff hist −3 Lanoxin tablet/adult indications and dosage No edit summary
- 15:2515:25, 20 March 2014 diff hist −1 Lanoxin tablet/adverse reactions No edit summary
- 15:2515:25, 20 March 2014 diff hist +8,034 N Template:Lanoxin tablet Created page with "{|class="infobox" style="margin: 0 0 0 0; border: 0; float: right; width: 180px; background: #104E8B; border-radius: 10px 10px 10px 10px;" cellpadding="0" cellspacing="0"; |- ..." current
- 15:2315:23, 20 March 2014 diff hist +2,545 Lanoxin tablet/adverse reactions No edit summary
- 15:1615:16, 20 March 2014 diff hist +1 Lanoxin tablet/adverse reactions No edit summary
- 15:1615:16, 20 March 2014 diff hist +3 N Lanoxin tablet/adverse reactions Created page with "123"
- 15:1015:10, 20 March 2014 diff hist +746 Lanoxin tablet No edit summary
- 14:4814:48, 20 March 2014 diff hist +60 Digoxin No edit summary
- 14:4414:44, 20 March 2014 diff hist 0 Digoxin No edit summary
- 14:4414:44, 20 March 2014 diff hist 0 N File:Digoxin structure 2.png No edit summary current
- 14:4214:42, 20 March 2014 diff hist −888 Digoxin No edit summary
19 March 2014
- 21:4121:41, 19 March 2014 diff hist +40 Lanoxin tablet/pediatric indications and dosage No edit summary
- 21:3921:39, 19 March 2014 diff hist +443 N Lanoxin tablet/pediatric indications and dosage Created page with "Heart failure Loading dose: 5-10 years old 20-45 mcg/kg Administer half the total loading dose initially, then ¼ the loading dose every 6 to 8 hours twice. >10 year ol..."
- 20:4820:48, 19 March 2014 diff hist +1,292 Lanoxin tablet No edit summary
- 20:2820:28, 19 March 2014 diff hist +137 N Lanoxin tablet/contraindications Created page with "__NOTOC__ {{Labeltemplate}} {{CMG}} ===Contraindications=== *Ventricular fibrillation *Hypersensitivity to digoxin {{DrugReflist}}"
- 20:2620:26, 19 March 2014 diff hist +4 Lanoxin tablet/warnings No edit summary current
- 20:2620:26, 19 March 2014 diff hist +24 Lanoxin tablet/warnings No edit summary
- 20:2520:25, 19 March 2014 diff hist +25 Lanoxin tablet/warnings No edit summary
- 20:2320:23, 19 March 2014 diff hist +1,823 N Lanoxin tablet/warnings Created page with "__NOTOC__ {{Labeltemplate}} {{CMG}} ===Warnings=== Sinus Node Disease and AV Block Because digoxin slows sinoatrial and AV conduction, the drug commonly prolongs the PR i..."
- 19:2719:27, 19 March 2014 diff hist +1,775 Lanoxin tablet No edit summary
- 19:2219:22, 19 March 2014 diff hist +74 Lanoxin tablet No edit summary
- 19:0319:03, 19 March 2014 diff hist +471 Lanoxin tablet No edit summary
- 18:3318:33, 19 March 2014 diff hist −20 Lanoxin tablet/adult indications and dosage →Off-Label Use and Dosage (Adult)
- 18:3218:32, 19 March 2014 diff hist +4 Lanoxin tablet/adult indications and dosage →Off-Label Use and Dosage (Adult)
- 18:3118:31, 19 March 2014 diff hist +1 Lanoxin tablet No edit summary
- 18:2418:24, 19 March 2014 diff hist +526 Lanoxin tablet/adult indications and dosage No edit summary
- 18:2218:22, 19 March 2014 diff hist +429 Lanoxin tablet No edit summary
- 18:0118:01, 19 March 2014 diff hist −482 Lanoxin tablet/adult indications and dosage Replaced content with "__NOTOC__ {{Lanoxin}} {{CMG}}"
- 17:5617:56, 19 March 2014 diff hist −2 Lanoxin tablet/adult indications and dosage No edit summary
- 17:4417:44, 19 March 2014 diff hist +513 N Lanoxin tablet/adult indications and dosage Created page with "__NOTOC__ {{Lanoxin}} {{CMG}} ===FDA-Labeled Indications and Dosage (Adult)=== ====Heart failure==== =====Loading dose:===== 10-15 mcg/kg PO half of the dose is given initi..."
- 15:4815:48, 19 March 2014 diff hist +242 N Lanoxin tablet Created page with "{{Label template |drugClass=Cardiac glycoside |indication=heart failure and atrial fibrillation |adverseReactions=AV block, tachycardia, GI symptoms and visu..."
16 March 2014
- 20:0220:02, 16 March 2014 diff hist +659 WBR1055 No edit summary
- 19:5319:53, 16 March 2014 diff hist −383 WBR1055 No edit summary
- 19:4119:41, 16 March 2014 diff hist −122 WBR1055 No edit summary
- 19:4019:40, 16 March 2014 diff hist +826 WBR1055 No edit summary
- 19:3919:39, 16 March 2014 diff hist −704 WBR1055 No edit summary
- 18:5218:52, 16 March 2014 diff hist +2,795 N WBR1055 Created page with "{{WBRQuestion |QuestionAuthor={{AK}} |ExamType=USMLE Step 3 |MainCategory=Primary Care Office |SubCategory=Allergy/Immunology, Respiratory |MainCategory=Primary Care Office |S..."
13 March 2014
- 06:4906:49, 13 March 2014 diff hist 0 Diltiazem hydrochloride tablet extended release indications and usage No edit summary
- 06:4806:48, 13 March 2014 diff hist −15 Amlodipine →Norvasc®
- 06:4706:47, 13 March 2014 diff hist +1,425 N Amlodipine warnings and precautions Created page with "__NOTOC__ {{Amlodipine}} {{CMG}}; {{AE}} {{AK}} ==Warnings and Precautions== ===Hypotension=== Symptomatic hypotension is possible, particularly in patients with severe..."
- 06:4106:41, 13 March 2014 diff hist −86 Template:Amlodipine No edit summary current
- 06:3906:39, 13 March 2014 diff hist +18 Diltiazem hydrochloride tablet labels and packages No edit summary
- 06:3906:39, 13 March 2014 diff hist +30 Diltiazem hydrochloride tablet labels and packages No edit summary
- 06:3406:34, 13 March 2014 diff hist 0 Diltiazem hydrochloride tablet how supplied storage and handling No edit summary
- 06:3306:33, 13 March 2014 diff hist 0 Diltiazem hydrochloride tablet nonclinical toxicology No edit summary
- 06:3206:32, 13 March 2014 diff hist 0 Diltiazem hydrochloride tablet clinical pharmacology No edit summary
- 06:3106:31, 13 March 2014 diff hist +17 Diltiazem hydrochloride tablet description No edit summary
- 06:0706:07, 13 March 2014 diff hist 0 Diltiazem hydrochloride tablet overdosage No edit summary
- 06:0506:05, 13 March 2014 diff hist 0 Diltiazem hydrochloride tablet use in specific populations No edit summary
- 06:0406:04, 13 March 2014 diff hist 0 Diltiazem hydrochloride tablet drug interactions No edit summary
- 06:0406:04, 13 March 2014 diff hist 0 Diltiazem hydrochloride tablet adverse reactions No edit summary
- 06:0306:03, 13 March 2014 diff hist 0 Diltiazem hydrochloride tablet precautions No edit summary
- 06:0106:01, 13 March 2014 diff hist 0 Diltiazem hydrochloride tablet warnings No edit summary
- 06:0106:01, 13 March 2014 diff hist 0 Diltiazem hydrochloride tablet contraindications No edit summary
- 06:0006:00, 13 March 2014 diff hist 0 Diltiazem hydrochloride tablet dosage and administration No edit summary
- 05:4405:44, 13 March 2014 diff hist 0 Diltiazem hydrochloride tablet indications and usage No edit summary
- 05:3905:39, 13 March 2014 diff hist +23 DIGOXIN tablet labels and packages No edit summary
- 05:3505:35, 13 March 2014 diff hist −3 DIGOXIN tablet patient counseling information No edit summary
- 05:3405:34, 13 March 2014 diff hist −2 DIGOXIN tablet how supplied storage and handling No edit summary
- 05:3305:33, 13 March 2014 diff hist +2 DIGOXIN tablet clinical studies No edit summary
- 05:3205:32, 13 March 2014 diff hist −6 DIGOXIN tablet nonclinical toxicology No edit summary
- 05:2205:22, 13 March 2014 diff hist −11 DIGOXIN tablet clinical pharmacology No edit summary
- 05:1705:17, 13 March 2014 diff hist +15 DIGOXIN tablet description No edit summary
- 05:1605:16, 13 March 2014 diff hist +2,879 DIGOXIN tablet overdosage No edit summary
- 05:1405:14, 13 March 2014 diff hist −6 DIGOXIN injection overdosage No edit summary
- 05:1305:13, 13 March 2014 diff hist +3 DIGOXIN injection overdosage →Chronic Overdose
- 05:1205:12, 13 March 2014 diff hist +44 DIGOXIN injection overdosage →Acute Overdose
- 05:0905:09, 13 March 2014 diff hist 0 DIGOXIN tablet overdosage No edit summary
- 05:0505:05, 13 March 2014 diff hist −27 DIGOXIN tablet overdosage No edit summary
- 05:0405:04, 13 March 2014 diff hist −28 DIGOXIN tablet use in specific populations No edit summary
- 05:0105:01, 13 March 2014 diff hist +17 DIGOXIN tablet drug interactions No edit summary
- 05:0105:01, 13 March 2014 diff hist −15 DIGOXIN tablet drug interactions No edit summary
- 05:0005:00, 13 March 2014 diff hist −28 DIGOXIN tablet adverse reactions No edit summary
- 04:5104:51, 13 March 2014 diff hist −30 DIGOXIN tablet warnings and precautions No edit summary
- 04:5004:50, 13 March 2014 diff hist +1 DIGOXIN tablet contraindications No edit summary
- 04:4804:48, 13 March 2014 diff hist −7 DIGOXIN tablet contraindications No edit summary
- 04:4704:47, 13 March 2014 diff hist −1 DIGOXIN tablet dosage forms and strengths No edit summary
- 04:4604:46, 13 March 2014 diff hist +57 DIGOXIN tablet dosage and administration No edit summary
- 04:4204:42, 13 March 2014 diff hist −11 DIGOXIN tablet indications and usage No edit summary
- 04:4004:40, 13 March 2014 diff hist +24 DIGOXIN injection labels and packages No edit summary
- 04:3904:39, 13 March 2014 diff hist +15 Amlodipine No edit summary
- 04:3604:36, 13 March 2014 diff hist +22 DIGOXIN injection patient counseling information No edit summary
- 04:3404:34, 13 March 2014 diff hist −2 DIGOXIN injection how supplied storage and handling No edit summary
- 04:3304:33, 13 March 2014 diff hist −10 DIGOXIN injection clinical studies No edit summary
- 04:3204:32, 13 March 2014 diff hist 0 DIGOXIN injection nonclinical toxicology No edit summary
- 04:2904:29, 13 March 2014 diff hist −6 DIGOXIN injection nonclinical toxicology No edit summary
- 04:2804:28, 13 March 2014 diff hist −3 DIGOXIN injection clinical pharmacology No edit summary
- 04:2604:26, 13 March 2014 diff hist +15 DIGOXIN injection description No edit summary
- 04:2504:25, 13 March 2014 diff hist +23 DIGOXIN injection overdosage No edit summary
- 04:2204:22, 13 March 2014 diff hist 0 DIGOXIN injection use in specific populations No edit summary
- 04:2004:20, 13 March 2014 diff hist −45 DIGOXIN injection use in specific populations No edit summary
- 04:1804:18, 13 March 2014 diff hist +21 DIGOXIN injection drug interactions No edit summary
- 04:1704:17, 13 March 2014 diff hist −21 DIGOXIN injection adverse reactions No edit summary
- 04:1604:16, 13 March 2014 diff hist −23 DIGOXIN injection warnings and precautions No edit summary
- 04:1404:14, 13 March 2014 diff hist −6 DIGOXIN injection contraindications No edit summary
- 04:1404:14, 13 March 2014 diff hist −1 DIGOXIN injection contraindications No edit summary
- 04:1304:13, 13 March 2014 diff hist 0 DIGOXIN injection dosage forms and strengths No edit summary
- 04:1304:13, 13 March 2014 diff hist −1 DIGOXIN injection dosage forms and strengths No edit summary
- 04:1204:12, 13 March 2014 diff hist 0 DIGOXIN injection dosage and administration No edit summary
- 04:1204:12, 13 March 2014 diff hist +40 DIGOXIN injection dosage and administration No edit summary
- 04:0904:09, 13 March 2014 diff hist −10 DIGOXIN injection indications and usage No edit summary
- 04:0504:05, 13 March 2014 diff hist −3 Fondaparinux No edit summary
- 04:0304:03, 13 March 2014 diff hist −1 Rivaroxaban contraindications No edit summary
- 04:0204:02, 13 March 2014 diff hist 0 Rivaroxaban drug interactions No edit summary
- 03:5903:59, 13 March 2014 diff hist +31 Rivaroxaban drug interactions →Drug-Disease Interactions with Drugs that Inhibit Cytochrome P450 3A4 Enzymes and Drug Transport Systems
- 03:5703:57, 13 March 2014 diff hist −55 Rivaroxaban drug interactions No edit summary
- 03:5503:55, 13 March 2014 diff hist −15 Rivaroxaban use in specific populations No edit summary
- 03:5403:54, 13 March 2014 diff hist −44 Rivaroxaban use in specific populations No edit summary
- 03:5303:53, 13 March 2014 diff hist −13 Rivaroxaban overdosage No edit summary
- 03:5203:52, 13 March 2014 diff hist −2 Rivaroxaban overdosage No edit summary
- 03:5103:51, 13 March 2014 diff hist +67 Rivaroxaban clinical pharmacology No edit summary
- 03:4803:48, 13 March 2014 diff hist −6 Rivaroxaban nonclinical toxicology No edit summary
- 03:4703:47, 13 March 2014 diff hist +52 Rivaroxaban clinical studies No edit summary
- 03:4503:45, 13 March 2014 diff hist +203 Rivaroxaban clinical studies No edit summary
- 03:3903:39, 13 March 2014 diff hist 0 Rivaroxaban how supplied storage and handling No edit summary
- 03:3803:38, 13 March 2014 diff hist +49 Rivaroxaban how supplied storage and handling No edit summary
- 03:3103:31, 13 March 2014 diff hist −60 Rivaroxaban patient counseling information No edit summary
- 03:2903:29, 13 March 2014 diff hist +23 Rivaroxaban labels and packages No edit summary
- 03:2703:27, 13 March 2014 diff hist −30 Rivaroxaban warnings and precautions No edit summary
- 03:2503:25, 13 March 2014 diff hist −27 Rivaroxaban warnings and precautions No edit summary
- 03:2403:24, 13 March 2014 diff hist −17 Rivaroxaban warnings and precautions →5.2 Risk of Bleeding
- 03:2303:23, 13 March 2014 diff hist −18 Rivaroxaban warnings and precautions →5.1 Increased Risk of Thrombotic Events after Premature Discontinuation
- 03:2203:22, 13 March 2014 diff hist +52 Rivaroxaban adverse reactions No edit summary
- 03:1703:17, 13 March 2014 diff hist −1 Rivaroxaban adverse reactions No edit summary
- 03:1603:16, 13 March 2014 diff hist −1 Rivaroxaban warnings and precautions No edit summary
- 03:1603:16, 13 March 2014 diff hist −2 Rivaroxaban contraindications No edit summary
- 03:1203:12, 13 March 2014 diff hist −1 Rivaroxaban dosage forms and strengths →3 DOSAGE FORMS AND STRENGTHS
- 03:1103:11, 13 March 2014 diff hist +1 Rivaroxaban dosage and administration →Missed Dose
- 03:1103:11, 13 March 2014 diff hist +1 Rivaroxaban dosage and administration →Prophylaxis of Deep Vein Thrombosis Following Hip or Knee Replacement Surgery
- 03:0203:02, 13 March 2014 diff hist −34 Rivaroxaban dosage and administration →Prophylaxis of Deep Vein Thrombosis Following Hip or Knee Replacement Surgery
- 02:5902:59, 13 March 2014 diff hist −42 Rivaroxaban dosage and administration →Administration Options
- 02:5602:56, 13 March 2014 diff hist +34 Rivaroxaban dosage and administration →Discontinuation for Surgery and other Interventions
- 02:5202:52, 13 March 2014 diff hist +204 Rivaroxaban dosage and administration No edit summary
- 02:4702:47, 13 March 2014 diff hist +136 Rivaroxaban dosage and administration No edit summary
- 02:4202:42, 13 March 2014 diff hist −14 Rivaroxaban dosage and administration No edit summary
- 02:4102:41, 13 March 2014 diff hist −16 Rivaroxaban indications and usage No edit summary
- 02:3602:36, 13 March 2014 diff hist 0 Template:Methyldopa No edit summary current
- 01:4301:43, 13 March 2014 diff hist 0 Amlodipine clinical pharmacology No edit summary
- 01:4201:42, 13 March 2014 diff hist +8 Amlodipine description No edit summary
- 01:4101:41, 13 March 2014 diff hist 0 Amlodipine overdosage No edit summary
- 01:4101:41, 13 March 2014 diff hist 0 Amlodipine use in specific populations No edit summary
- 01:3901:39, 13 March 2014 diff hist +4 Methyldopa →Category
- 01:3701:37, 13 March 2014 diff hist +34 Methyldopa →Category
- 01:3501:35, 13 March 2014 diff hist −1 Amlodipine labels and packages No edit summary
- 01:3001:30, 13 March 2014 diff hist −3 Amlodipine labels and packages No edit summary
- 01:2901:29, 13 March 2014 diff hist +23 Norvasc ←Redirected page to Amlodipine current
- 01:2401:24, 13 March 2014 diff hist −1 Amlodipine patient counseling information No edit summary
- 01:2401:24, 13 March 2014 diff hist −18 Amlodipine how supplied storage and handling No edit summary
- 01:2301:23, 13 March 2014 diff hist −22 Amlodipine clinical studies No edit summary
- 01:2201:22, 13 March 2014 diff hist −6 Amlodipine nonclinical toxicology No edit summary
- 01:1901:19, 13 March 2014 diff hist −18 Amlodipine clinical pharmacology No edit summary
- 01:1901:19, 13 March 2014 diff hist −2 Amlodipine description No edit summary
- 01:1801:18, 13 March 2014 diff hist −2 Amlodipine overdosage →10 OVERDOSAGE
- 01:1801:18, 13 March 2014 diff hist −13 Amlodipine use in specific populations No edit summary
- 01:1401:14, 13 March 2014 diff hist −44 Amlodipine drug interactions No edit summary
- 01:1201:12, 13 March 2014 diff hist −7 Amlodipine adverse reactions No edit summary
- 01:1101:11, 13 March 2014 diff hist −1 Amlodipine dosage forms and strengths No edit summary
- 01:1001:10, 13 March 2014 diff hist −25 Amlodipine dosage and administration No edit summary
- 01:1001:10, 13 March 2014 diff hist −7 Amlodipine indications and usage No edit summary
- 01:0701:07, 13 March 2014 diff hist +3 Amlodipine No edit summary
12 March 2014
- 23:0723:07, 12 March 2014 diff hist +273 Methyldopa No edit summary
- 23:0623:06, 12 March 2014 diff hist +382 Methyldopa No edit summary
- 22:5522:55, 12 March 2014 diff hist +1,141 Amlodipine drug interactions No edit summary
- 21:4721:47, 12 March 2014 diff hist −4 Amlodipine use in specific populations No edit summary
- 21:4621:46, 12 March 2014 diff hist +414 Amlodipine contraindications No edit summary
- 21:3021:30, 12 March 2014 diff hist 0 N File:Norvasc3.png No edit summary current
- 21:2921:29, 12 March 2014 diff hist 0 N File:Norvasc1.png No edit summary current
- 21:2821:28, 12 March 2014 diff hist +38 Amlodipine adverse reactions No edit summary
- 21:2521:25, 12 March 2014 diff hist +17 Amlodipine description No edit summary
- 21:2521:25, 12 March 2014 diff hist 0 N File:Norvasc4.png No edit summary current
- 21:2421:24, 12 March 2014 diff hist 0 Amlodipine description No edit summary
- 21:2021:20, 12 March 2014 diff hist −6 Amlodipine nonclinical toxicology No edit summary
- 21:1921:19, 12 March 2014 diff hist 0 Amlodipine nonclinical toxicology No edit summary
- 21:1921:19, 12 March 2014 diff hist −2 Amlodipine labels and packages No edit summary
- 21:1821:18, 12 March 2014 diff hist +23 Amlodipine labels and packages No edit summary
- 21:1721:17, 12 March 2014 diff hist 0 Amlodipine how supplied storage and handling No edit summary
- 21:1621:16, 12 March 2014 diff hist 0 N File:Norvasc7.png No edit summary current
- 21:1621:16, 12 March 2014 diff hist 0 Amlodipine clinical studies No edit summary
- 21:1621:16, 12 March 2014 diff hist +51 Amlodipine clinical studies No edit summary
- 21:0521:05, 12 March 2014 diff hist 0 Amlodipine dosage forms and strengths No edit summary
- 21:0521:05, 12 March 2014 diff hist 0 Amlodipine dosage and administration No edit summary
- 21:0521:05, 12 March 2014 diff hist 0 Amlodipine indications and usage No edit summary
- 20:5420:54, 12 March 2014 diff hist 0 Amlodipine No edit summary
- 20:3420:34, 12 March 2014 diff hist 0 Hydralazine injection how supplied storage and handling No edit summary
- 20:3320:33, 12 March 2014 diff hist +23 Hydralazine injection labels and packages No edit summary
- 20:2720:27, 12 March 2014 diff hist 0 Hydralazine injection clinical pharmacology No edit summary
- 20:2720:27, 12 March 2014 diff hist +17 Hydralazine injection description No edit summary
- 20:2720:27, 12 March 2014 diff hist 0 Hydralazine injection description No edit summary
- 20:2620:26, 12 March 2014 diff hist 0 Hydralazine injection overdosage No edit summary
- 20:2620:26, 12 March 2014 diff hist 0 Hydralazine injection use in specific populations No edit summary
- 20:2620:26, 12 March 2014 diff hist 0 Hydralazine injection adverse reactions No edit summary
- 20:2520:25, 12 March 2014 diff hist 0 Hydralazine injection precautions No edit summary
- 20:2520:25, 12 March 2014 diff hist 0 Hydralazine injection warnings No edit summary
- 20:2520:25, 12 March 2014 diff hist 0 Hydralazine injection contraindications No edit summary
- 20:2520:25, 12 March 2014 diff hist 0 Hydralazine injection dosage and administration No edit summary
- 20:1720:17, 12 March 2014 diff hist 0 Hydralazine injection indications and usage No edit summary
- 20:1720:17, 12 March 2014 diff hist 0 Hydralazine tablet labels and packages No edit summary
- 20:1620:16, 12 March 2014 diff hist 0 Hydralazine tablet how supplied storage and handling No edit summary
- 20:1620:16, 12 March 2014 diff hist +27 Hydralazine tablet nonclinical toxicology No edit summary
- 20:1620:16, 12 March 2014 diff hist 0 Hydralazine tablet clinical pharmacology No edit summary
- 20:1620:16, 12 March 2014 diff hist 0 Hydralazine tablet description No edit summary
- 20:1520:15, 12 March 2014 diff hist 0 Hydralazine tablet overdosage No edit summary
- 20:1520:15, 12 March 2014 diff hist 0 Hydralazine tablet use in specific populations No edit summary
- 20:1420:14, 12 March 2014 diff hist 0 Hydralazine tablet adverse reactions No edit summary
- 20:1420:14, 12 March 2014 diff hist 0 Hydralazine tablet precautions No edit summary
- 20:1420:14, 12 March 2014 diff hist 0 Hydralazine tablet warnings No edit summary
- 20:1420:14, 12 March 2014 diff hist 0 Hydralazine tablet contraindications No edit summary
- 20:1420:14, 12 March 2014 diff hist 0 Hydralazine tablet dosage and administration No edit summary
- 20:1320:13, 12 March 2014 diff hist 0 Hydralazine tablet indications and usage No edit summary
- 20:1020:10, 12 March 2014 diff hist +25 Methyldopa injection labels and packages No edit summary
- 20:0920:09, 12 March 2014 diff hist 0 Methyldopa injection how supplied storage and handling →HOW SUPPLIED
- 20:0920:09, 12 March 2014 diff hist −1 Methyldopa injection use in specific populations No edit summary
- 20:0920:09, 12 March 2014 diff hist 0 Methyldopa injection dosage and administration No edit summary
- 20:0820:08, 12 March 2014 diff hist 0 Methyldopa injection indications and usage No edit summary
- 20:0820:08, 12 March 2014 diff hist 0 Methyldopa tablet labels and packages No edit summary
- 20:0820:08, 12 March 2014 diff hist −1 Methyldopa tablet use in specific populations No edit summary
- 20:0720:07, 12 March 2014 diff hist 0 Methyldopa tablet dosage and administration No edit summary
- 20:0720:07, 12 March 2014 diff hist 0 Methyldopa tablet indications and usage No edit summary
- 20:0620:06, 12 March 2014 diff hist 0 Mecamylamine patient counseling information No edit summary
- 20:0520:05, 12 March 2014 diff hist 0 Mecamylamine use in specific populations No edit summary
- 20:0420:04, 12 March 2014 diff hist 0 Mecamylamine dosage and administration No edit summary
- 20:0420:04, 12 March 2014 diff hist 0 Mecamylamine indications and usage No edit summary
- 20:0320:03, 12 March 2014 diff hist 0 Doxazosin labels and packages No edit summary
- 20:0320:03, 12 March 2014 diff hist 0 Doxazosin patient counseling information No edit summary
- 20:0220:02, 12 March 2014 diff hist 0 Doxazosin use in specific populations No edit summary
- 20:0120:01, 12 March 2014 diff hist 0 Doxazosin dosage and administration No edit summary
- 20:0120:01, 12 March 2014 diff hist 0 Doxazosin indications and usage No edit summary
- 20:0020:00, 12 March 2014 diff hist −118 Doxazosin No edit summary
- 19:5919:59, 12 March 2014 diff hist 0 Terazosin labels and packages No edit summary
- 19:5819:58, 12 March 2014 diff hist 0 Terazosin use in specific populations No edit summary
- 19:5819:58, 12 March 2014 diff hist 0 Terazosin dosage and administration No edit summary
- 19:5819:58, 12 March 2014 diff hist 0 Terazosin indications and usage No edit summary
- 19:5719:57, 12 March 2014 diff hist 0 Prazosin labels and packages No edit summary
- 19:5719:57, 12 March 2014 diff hist +17 Prazosin how supplied storage and handling No edit summary
- 19:5719:57, 12 March 2014 diff hist 0 Prazosin use in specific populations No edit summary
- 19:5619:56, 12 March 2014 diff hist 0 Prazosin dosage and administration No edit summary
- 19:5619:56, 12 March 2014 diff hist 0 Prazosin indications and usage No edit summary
- 19:5219:52, 12 March 2014 diff hist +32 Prazosin labels and packages No edit summary
- 19:5119:51, 12 March 2014 diff hist +34 Prazosin patient counseling information No edit summary
- 19:5119:51, 12 March 2014 diff hist 0 Prazosin how supplied storage and handling No edit summary
- 19:5119:51, 12 March 2014 diff hist 0 Prazosin nonclinical toxicology No edit summary
- 19:5119:51, 12 March 2014 diff hist 0 Prazosin clinical pharmacology No edit summary
- 19:5019:50, 12 March 2014 diff hist +17 Prazosin description No edit summary
- 19:5019:50, 12 March 2014 diff hist 0 Prazosin overdosage No edit summary
- 19:5019:50, 12 March 2014 diff hist 0 Prazosin use in specific populations No edit summary
- 19:4919:49, 12 March 2014 diff hist 0 Prazosin adverse reactions No edit summary
- 19:4919:49, 12 March 2014 diff hist 0 Prazosin precautions No edit summary
- 19:4919:49, 12 March 2014 diff hist 0 Prazosin warnings No edit summary
- 19:4819:48, 12 March 2014 diff hist 0 Prazosin contraindications No edit summary
- 19:4819:48, 12 March 2014 diff hist 0 Prazosin dosage and administration No edit summary
- 19:4819:48, 12 March 2014 diff hist 0 Prazosin indications and usage No edit summary
- 19:4519:45, 12 March 2014 diff hist +22 Template:Terazosin No edit summary current
- 19:4419:44, 12 March 2014 diff hist −193 Prazosin No edit summary
- 19:4219:42, 12 March 2014 diff hist −270 Template:Prazosin No edit summary current
- 19:4219:42, 12 March 2014 diff hist −272 Template:Terazosin No edit summary
- 19:4019:40, 12 March 2014 diff hist −3 Terazosin labels and packages →Labels And PAckages
- 19:4019:40, 12 March 2014 diff hist +24 Terazosin labels and packages No edit summary
- 19:3919:39, 12 March 2014 diff hist +1 Terazosin labels and packages No edit summary
- 19:3819:38, 12 March 2014 diff hist 0 Terazosin patient counseling information No edit summary
- 19:3819:38, 12 March 2014 diff hist 0 Terazosin how supplied storage and handling No edit summary
- 19:3719:37, 12 March 2014 diff hist +1,502 Terazosin precautions No edit summary
- 19:3619:36, 12 March 2014 diff hist +2,716 Terazosin nonclinical toxicology No edit summary
- 19:3419:34, 12 March 2014 diff hist +16 Terazosin clinical pharmacology No edit summary
- 19:3119:31, 12 March 2014 diff hist +85 Terazosin clinical pharmacology No edit summary
- 19:2919:29, 12 March 2014 diff hist +17 Terazosin description No edit summary
- 19:2919:29, 12 March 2014 diff hist 0 Terazosin overdosage No edit summary
- 19:2919:29, 12 March 2014 diff hist −1 Terazosin use in specific populations No edit summary
- 19:2819:28, 12 March 2014 diff hist +2 Terazosin adverse reactions No edit summary
- 19:2819:28, 12 March 2014 diff hist +70 Terazosin adverse reactions No edit summary
- 19:2619:26, 12 March 2014 diff hist 0 Terazosin precautions No edit summary
- 19:2619:26, 12 March 2014 diff hist 0 Terazosin warnings No edit summary
- 19:2619:26, 12 March 2014 diff hist 0 Terazosin contraindications No edit summary
- 19:2619:26, 12 March 2014 diff hist 0 Terazosin dosage and administration No edit summary
- 19:2519:25, 12 March 2014 diff hist 0 Terazosin indications and usage No edit summary
- 19:2519:25, 12 March 2014 diff hist −118 Terazosin No edit summary
- 18:3818:38, 12 March 2014 diff hist +44 Doxazosin patient counseling information No edit summary
- 18:3818:38, 12 March 2014 diff hist +23 N PDE-5 inhibitors ←Redirected page to Sildenafil current
- 18:3418:34, 12 March 2014 diff hist −272 Template:Doxazosin No edit summary current
- 18:2618:26, 12 March 2014 diff hist +25 Doxazosin labels and packages No edit summary
- 18:2518:25, 12 March 2014 diff hist 0 Doxazosin patient counseling information No edit summary
- 18:2418:24, 12 March 2014 diff hist +18 Doxazosin how supplied storage and handling No edit summary
- 18:2318:23, 12 March 2014 diff hist −1 Doxazosin use in specific populations No edit summary
- 18:2318:23, 12 March 2014 diff hist +27 Doxazosin nonclinical toxicology No edit summary
- 18:2218:22, 12 March 2014 diff hist 0 Doxazosin nonclinical toxicology No edit summary
- 18:2018:20, 12 March 2014 diff hist +83 Doxazosin clinical pharmacology No edit summary
- 18:1618:16, 12 March 2014 diff hist 0 Doxazosin description No edit summary
